EPISODE · Sep 4, 2024 · 13 MIN
196. Reversing MS Damage: The Promising Potential of PIPE-307 to Regrow Myelin
from The MSing Link · host Dr. Gretchen Hawley PT, DPT, MSCS
Today, we're going to be talking about a specific drug that has been shown in research thus far to help with remyelination. Do you remember back in the day, there was research in the MS world that was looking at the possible effects of clemastine on multiple sclerosis. The hope here was that it would help with remyelination, AKA building myelin. That same research has been integral in helping researchers develop an even more effective drug that is currently in phase two trials, and it's showing really promising results for remyelination in humans! And it's about time you know about it! Resources mentioned in this episode: The MSing Link Podcast, Episode Number 186: Spotify / Apple / Podcast Website Clinical Trials Website: ClinicalTrials.gov Study to Evaluate the Safety and Efficacy of PIPE-307 in Subjects With Relapsing-Remitting Multiple Sclerosis (VISTA) Additional Resources: https://www.doctorgretchenhawley.com/insider Reach out to Me: [email protected] Website: www.MSingLink.com Social: ★ Facebook: https://www.facebook.com/groups/mswellness ★ Instagram: https://www.instagram.com/doctor.gretchen ★ YouTube: https://www.youtube.com/c/doctorgretchenhawley?sub_confirmation=1 → Game Changers Course: https://www.doctorgretchenhawley.com/GameChangersCourse → Total Core Program: https://www.doctorgretchenhawley.com/TotalCoreProgram → The MSing Link: https://www.doctorgretchenhawley.com/TheMSingLink
Embed this episode
NOW PLAYING
196. Reversing MS Damage: The Promising Potential of PIPE-307 to Regrow Myelin
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.